File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/S0002-9343(03)00135-9
- Scopus: eid_2-s2.0-0037627874
- PMID: 12867236
- WOS: WOS:000184134900010
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: An open-label study
Title | Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: An open-label study |
---|---|
Authors | |
Issue Date | 2003 |
Publisher | Excerpta Medica, Inc. The Journal's web site is located at http://www.elsevier.com/locate/amj |
Citation | American Journal Of Medicine, 2003, v. 115 n. 1, p. 59-62 How to Cite? |
Persistent Identifier | http://hdl.handle.net/10722/162690 |
ISSN | 2023 Impact Factor: 5.1 2023 SCImago Journal Rankings: 1.063 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mok, CC | en_US |
dc.contributor.author | Lau, CS | en_US |
dc.contributor.author | Wong, RWS | en_US |
dc.date.accessioned | 2012-09-05T05:22:23Z | - |
dc.date.available | 2012-09-05T05:22:23Z | - |
dc.date.issued | 2003 | en_US |
dc.identifier.citation | American Journal Of Medicine, 2003, v. 115 n. 1, p. 59-62 | en_US |
dc.identifier.issn | 0002-9343 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/162690 | - |
dc.language | eng | en_US |
dc.publisher | Excerpta Medica, Inc. The Journal's web site is located at http://www.elsevier.com/locate/amj | en_US |
dc.relation.ispartof | American Journal of Medicine | en_US |
dc.subject.mesh | Administration, Oral | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Anti-Inflammatory Agents - Therapeutic Use | en_US |
dc.subject.mesh | Antibodies, Antinuclear - Immunology | en_US |
dc.subject.mesh | Azathioprine - Administration & Dosage - Therapeutic Use | en_US |
dc.subject.mesh | Cyclophosphamide - Administration & Dosage - Therapeutic Use | en_US |
dc.subject.mesh | Drug Therapy, Combination | en_US |
dc.subject.mesh | Drug Tolerance | en_US |
dc.subject.mesh | Enzyme-Linked Immunosorbent Assay | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Fluorescent Antibody Technique, Indirect | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Immunosuppressive Agents - Administration & Dosage - Therapeutic Use | en_US |
dc.subject.mesh | Lupus Erythematosus, Systemic - Drug Therapy - Immunology - Psychology | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Prednisone - Therapeutic Use | en_US |
dc.subject.mesh | Psychotic Disorders - Etiology | en_US |
dc.title | Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: An open-label study | en_US |
dc.type | Article | en_US |
dc.identifier.email | Lau, CS:cslau@hku.hk | en_US |
dc.identifier.authority | Lau, CS=rp01348 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/S0002-9343(03)00135-9 | en_US |
dc.identifier.pmid | 12867236 | en_US |
dc.identifier.scopus | eid_2-s2.0-0037627874 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0037627874&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 115 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.spage | 59 | en_US |
dc.identifier.epage | 62 | en_US |
dc.identifier.isi | WOS:000184134900010 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Mok, CC=7102344226 | en_US |
dc.identifier.scopusauthorid | Lau, CS=14035682100 | en_US |
dc.identifier.scopusauthorid | Wong, RWS=34875928200 | en_US |
dc.identifier.issnl | 0002-9343 | - |